%0 Journal Article %J J Neurovirol %D 2018 %T Antibody response to polyomavirus primary infection: high seroprevalence of Merkel cell polyomavirus and lymphoid tissue involvement. %A Cason, Carolina %A Monasta, Lorenzo %A Zanotta, Nunzia %A Campisciano, Giuseppina %A Maestri, Iva %A Tommasino, Massimo %A Pawlita, Michael %A Villani, Sonia %A Comar, Manola %A Delbue, Serena %X

Human polyomaviruses (HPyVs) asymptomatically infect the human population establishing latency in the host, and their seroprevalence can reach 90% in healthy adults. Few studies have focused on the pediatric population, and there are no reports regarding the seroprevalence of all the newly isolated HPyVs among Italian children. Therefore, we investigated the frequency of serum antibodies against 12 PyVs in 182 immunocompetent children from Northeast Italy, by means of a multiplex antibody detection system. Additionally, secondary lymphoid tissues were collected to analyze the presence of HPyV DNA sequences using a specific real-time PCRs or PCRs. Almost 100% of subjects were seropositive for at least one PyV. Seropositivity ranged from 3% for antibodies against simian virus 40 (SV40) in children from 0 to 3 years, to 91% for antibodies against WU polyomavirus (WUPyV) and HPyV10 in children from 8 to 17 years. The mean number of PyV for which children were seropositive increased with the increasing of age: 4 standard deviations (SD) 1.8 in the 0-3-year group, 5 (SD 1.9) in the 4-7-year group, and 6 (SD 2.2) in the 8-17-year group. JC polyomavirus (JCPyV) DNA was detected in 1% of the adenoids, WUPyV in 12% of the tonsils, and 28% of the adenoids, and Merkel cell polyomavirus (MCPyV) was present in 6 and 2% of the tonsils and adenoids, respectively. Our study gives new insights on the serological evidence of exposure to PyVs during childhood, and on their possible respiratory route of transmission.

%B J Neurovirol %V 24 %P 314-322 %8 2018 Jun %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/29330826?dopt=Abstract %R 10.1007/s13365-017-0612-2 %0 Journal Article %J Front Biosci (Elite Ed) %D 2018 %T Bariatric surgery drives major rearrangements of the intestinal microbiota including the biofilm composition. %A Campisciano, Giuseppina %A Cason, Carolina %A Palmisano, Silvia %A Giuricin, Michela %A Rizzardi, Alessia %A Croce, Lory Saveria %A De Manzini, Nicolo %A Comar, Manola %K Biofilms %K Case-Control Studies %K Gastric Bypass %K Gastrointestinal Microbiome %K Humans %K Intestinal Mucosa %K Obesity %K Prospective Studies %X

The intestinal microbiota disequilibrium has been associated with obesity, while the role of the gut mucosal biofilms in this pathology is still unknown. We analysed the changes in the intestinal microbiota of obese patients after bariatric surgery with the aim of disclosing the rearrangement of the biofilm configuration. Although the bariatric surgery drives major rearrangements of the gut microbiota, obese patients maintain the enterotype before and after surgery, as shown by normal weight patients, with an increase of and . The enterotype guarantees the strong ability to form a biofilm which allows a more efficient digestion of polysaccharides than planktonic communities and leads to the production of acetate which is a key player to inhibit enteropathogens. Additionally, the laparoscopic gastric bypass induces an increase of , a facultative anaerobic bacterium involved in intestinal and inflammatory disorders. Bariatric surgery influences the microbial composition of gut biofilm. Further studies are needed to elucidate the impact of this variation on recovery after surgery and on weight loss.

%B Front Biosci (Elite Ed) %V 10 %P 495-505 %8 2018 06 01 %G eng %1 http://www.ncbi.nlm.nih.gov/pubmed/29772522?dopt=Abstract %0 Journal Article %J J Cell Physiol %D 2017 %T SV40 Infection of Mesenchymal Stromal Cells From Wharton's Jelly Drives the Production of Inflammatory and Tumoral Mediators. %A Cason, Carolina %A Campisciano, Giuseppina %A Zanotta, Nunzia %A Valencic, Erica %A Delbue, Serena %A Bella, Ramona %A Comar, Manola %K Cell Line, Transformed %K Cell Separation %K Cell Transformation, Viral %K Chemokine CCL5 %K Chemokine CXCL9 %K Cytopathogenic Effect, Viral %K DNA, Viral %K Host-Pathogen Interactions %K Humans %K Inflammation Mediators %K Interleukin-12 Subunit p40 %K Interleukin-3 %K JC Virus %K Mesenchymal Stem Cells %K Real-Time Polymerase Chain Reaction %K Simian virus 40 %K Time Factors %K Up-Regulation %K Viral Load %K Virus Replication %K Wharton Jelly %X

The Mesenchymal Stromal Cells from umbilical cord Wharton's jelly (WJSCs) are a source of cells with high potentiality for the treatment of human immunological disorders. Footprints of the oncogenic viruses Simian Virus 40 (SV40) and JC Virus (JCPyV) have been recently detected in human WJSCs specimens. The aim of this study is to evaluate if WJSCs can be efficiently infected by these Polyomaviruses and if they can potentially exert tumoral activity. Cell culture experiments indicated that WJSCs could sustain both SV40 and JCPyV infections. A transient and lytic replication was observed for JCPyV, while SV40 persistently infected WJSCs over a long period of time, releasing a viral progeny at low titer without evident cytopathic effect (CPE). Considering the association between SV40 and human tumors and the reported ability of the oncogenic viruses to drive the host innate immune response to cell transformation, the expression profile of a large panel of immune mediators was evaluated in supernatants by the Bioplex platform. RANTES, IL-3, MIG, and IL-12p40, involved in chronic inflammation, cells differentiation, and transformation, were constantly measured at high concentration comparing to control. These findings represent a new aspect of SV40 biological activity in the humans, highlighting its interaction with specific host cellular pathways. In view of these results, it seems to be increasingly urgent to consider Polyomaviruses in the management of WJSCs for their safely use as promising therapeutic source. J. Cell. Physiol. 232: 3060-3066, 2017. © 2016 Wiley Periodicals, Inc.

%B J Cell Physiol %V 232 %P 3060-3066 %8 2017 Nov %G eng %N 11 %1 http://www.ncbi.nlm.nih.gov/pubmed/27925194?dopt=Abstract %R 10.1002/jcp.25723